Cargando…
Do women with high-risk HPV E6/E7 mRNA test positivity and NILM cytology need colposcopy?
PURPOSE: This study aimed to assess the value of an HPV E6/E7 mRNA assay and HPV 16 18/45 genotype assay combined with age stratification for triaging women negative for intraepithelial lesions or malignancy (NILM) cytology. METHODS: From January 2017 to December 2021, a total of 162,309 eligible wo...
Autores principales: | Liu, Ying, Jin, Xiu, Gong, Yingying, Ma, Yingying, Du, Beibei, Yang, Linqing, Wang, Yunfei, Zhu, Weipei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542237/ https://www.ncbi.nlm.nih.gov/pubmed/37773080 http://dx.doi.org/10.1186/s13027-023-00531-w |
Ejemplares similares
-
Diagnostic value of high-risk HPV E6/E7 mRNA in patients with ASCUS
por: Jin, Xiu, et al.
Publicado: (2023) -
HPV E6/E7 mRNA Testing Is More Specific than Cytology in Post-Colposcopy Follow-Up of Women with Negative Cervical Biopsy
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2011) -
Performance of Aptima HPV E6/E7 mRNA Test for Detection of Cervical Lesions in a Large Chinese Population
por: Yang, Zhujuan, et al.
Publicado: (2022) -
The Risk Stratification for Cervical Cancer and Precursors of Domestic HPV Testing With HPV 16/18 Genotyping in Women With NILM Cytology in CentralChina: A Cohort Study
por: Xu, Hui-Fang, et al.
Publicado: (2021) -
hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy
por: Carozzi, F, et al.
Publicado: (2013)